Aslan Pharmaceuticals Ltd ADR
(ASLN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Sales | 0 | 0 | 11,547 | 0 |
| Cost of Goods | N/A | N/A | 125 | N/A |
| Gross Profit | N/A | N/A | 11,422 | N/A |
| Operating Expenses | 42,348 | 39,140 | 20,247 | 0 |
| Operating Income | -42,348 | -39,140 | -8,700 | N/A |
| Interest Expense | 492 | 417 | 524 | 0 |
| Other Income | 669 | -336 | 175 | 0 |
| Pre-tax Income | -42,171 | -39,892 | -9,049 | 0 |
| Income Tax | 14 | N/A | N/A | N/A |
| Net Income Continuous | -42,186 | -39,892 | -9,049 | N/A |
| Net Income | $-42,186 | $-39,892 | $-9,049 | $N/A |
| EPS Basic Total Ops | -56.00 | -64.00 | -18.00 | N/A |
| EPS Basic Continuous Ops | -56.35 | -64.12 | -17.23 | N/A |
| EPS Diluted Total Ops | -56.00 | -64.00 | -18.00 | N/A |
| EPS Diluted Continuous Ops | -56.35 | -64.12 | -17.23 | N/A |
| EPS Diluted Before Non-Recurring Items | -56.00 | N/A | N/A | N/A |
| EBITDA(a) | $-42,106 | $-38,930 | $-8,624 | $N/A |